Literature DB >> 33467741

Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.

Urszula Bąchor1, Marcin Mączyński1.   

Abstract

Heterocyclic moieties, especially five and six-membered rings containing nitrogen, oxygen or sulfur atoms, are broadly distributed in nature. Among them, synthetic and natural alike are pharmacologically active compounds and have always been at the forefront of attention due to their pharmacological properties. Heterocycles can be divided into different groups based on the presence of characteristic structural motifs. The presence of β-amino acid and heterocyclic core in one compound is very interesting; additionally, it very often plays a vital role in their biological activity. Usually, such compounds are not considered to be chemicals containing a β-amino acid motif; however, considering them as this class of compounds may open new routes of their preparation and application as new drug precursors or even drugs. The possibility of their application as nonproteinogenic amino acid residues in peptide or peptide derivatives synthesis to prepare a new class of compounds is also promising. This review highlights the actual state of knowledge about β-amino acid moiety-containing heterocycles presenting antiviral, anti-inflammatory, antibacterial compounds, anaplastic lymphoma kinase (ALK) inhibitors, as well as agonist and antagonists of the receptors.

Entities:  

Keywords:  ALK inhibitors; agonists and antagonists of receptors; anti-inflammatory; antibacterial; antiviral; heterocyclic compounds; β-amino acid derivatives

Mesh:

Substances:

Year:  2021        PMID: 33467741      PMCID: PMC7829935          DOI: 10.3390/molecules26020438

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  88 in total

Review 1.  Unmet medical needs in antibacterial therapy.

Authors:  Louis B Rice
Journal:  Biochem Pharmacol       Date:  2005-11-08       Impact factor: 5.858

2.  Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties.

Authors:  B Gumusel; Q Hao; A Hyman; J K Chang; D R Kapusta; H Lippton
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 3.  Using β-Amino Acids and β-Peptide Templates to Create Bioactive Ligands and Biomaterials.

Authors:  Mark P Del Borgo; Ketav Kulkarni; Marie-Isabel Aguilar
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

Authors:  M J Sheardown; E O Nielsen; A J Hansen; P Jacobsen; T Honoré
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

5.  Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.

Authors:  R Wilson; C Langan; P Ball; K Bateman; R Pypstra
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

6.  Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.

Authors:  Angela Corona; Valentina Onnis; Alessandro Deplano; Giulia Bianco; Monica Demurtas; Simona Distinto; Yung-Chi Cheng; Stefano Alcaro; Francesca Esposito; Enzo Tramontano
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

Review 7.  Beta2-amino acids-syntheses, occurrence in natural products, and components of beta-peptides1,2.

Authors:  Gérald Lelais; Dieter Seebach
Journal:  Biopolymers       Date:  2004       Impact factor: 2.505

Review 8.  New β-Lactamase Inhibitors in the Clinic.

Authors:  Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  Infect Dis Clin North Am       Date:  2016-06       Impact factor: 5.982

Review 9.  Clinical use of tolmetin sodium in patients with ankylosing spondylitis: a review.

Authors:  A Calin
Journal:  J Clin Pharmacol       Date:  1983-07       Impact factor: 3.126

10.  Molecular identification of high and low affinity receptors for nicotinic acid.

Authors:  Alan Wise; Steven M Foord; Neil J Fraser; Ashley A Barnes; Nabil Elshourbagy; Michelle Eilert; Diane M Ignar; Paul R Murdock; Klaudia Steplewski; Andrew Green; Andrew J Brown; Simon J Dowell; Philip G Szekeres; David G Hassall; Fiona H Marshall; Shelagh Wilson; Nicholas B Pike
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

View more
  1 in total

1.  5-Amino-3-methyl-Isoxazole-4-carboxylic Acid as a Novel Unnatural Amino Acid in the Solid Phase Synthesis of α/β-Mixed Peptides.

Authors:  Urszula Bąchor; Agnieszka Lizak; Remigiusz Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.